SODIUM BICARBONATE TAB 600MG 600 MG
SODIUM BICARBONATE : 600 MG · DIN 00221619 · D.C. LABS LIMITED
Health Canada status: CANCELLED POST MARKET
What is SODIUM BICARBONATE TAB 600MG?
SODIUM BICARBONATE TAB 600MG 600 MG contains SODIUM BICARBONATE : 600 MG. It is listed in the Health Canada Drug Product Database under DIN 00221619, held by D.C. LABS LIMITED, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 11-Jul-2003. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00221619 |
|---|---|
| Brand name | SODIUM BICARBONATE TAB 600MG |
| Generic / active ingredient | SODIUM BICARBONATE : 600 MG |
| Manufacturer | D.C. LABS LIMITED |
| Strength | 600 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A02AH ANTACIDS WITH SODIUM BICARBONATE |
| AHFS class | 52:92.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 11-Jul-2003 |
| Original market date | 1971-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code A02AH ANTACIDS WITH SODIUM BICARBONATE. 0 of 9 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BAKING SODA USP | 100 % | POWDER | REGAL PHARMS, DIVISION OF BRADCAN CORPORATION | CANCELLED POST MARKET | DIN 00641634 |
| BRIOSCHI EFFERVESCENT ANTACID - 1.8GM/6GM | 1.8 G / 6 G | POWDER (EFFERVESCENT) | BRIOSCHI, INC. | CANCELLED POST MARKET | DIN 02230226 |
| BRIOSCHI EFFERVESCENT ANTACID PWR 280.3MG/GM | 269 MG | POWDER (EFFERVESCENT) | BRIOSCHI, INC. | CANCELLED POST MARKET | DIN 00677450 |
| BROMO SELTZER | 2.667 G / 7.3 G | GRANULES | TOWER LABORATORIES LTD | CANCELLED POST MARKET | DIN 02241892 |
| NORMO GASTRYL | 195 MG | TABLET (EFFERVESCENT) | SABEX INC | CANCELLED POST MARKET | DIN 00570826 |
| OHTA'S ISAN STOMACH POWDER | 497 MG / 1.3 G | POWDER | MAIZUN-CALBER (CANADA) LTD. | CANCELLED POST MARKET | DIN 02005085 |
| ROTER TABLETS | 25 MG | TABLET | ROTER PHARMACEUTISCHE FABRIEK | CANCELLED POST MARKET | DIN 00173797 |
| SODIUM BICARBONATE TAB 300MG | 300 MG | TABLET | D.C. LABS LIMITED | CANCELLED POST MARKET | DIN 00093068 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.